Introduction
Heterotrimeric G proteins are divided into four subfamilies (G s , G i , G q , and G 12 ) based on the sequences and functional similarities of their G ␣ subunits. G ␣ 16 is a of downstream effectors. Following the activation of G 16 , both G ␣ and G ␤ ␥ dimer can stimulate at least 3 subtypes of phospholipase C ␤ (PLC ␤ 1-3) and release inositol trisphosphate (IP 3 ) and diacylglycerol as revealed in an exogenous expression system [8] . These second messengers in turn trigger intracellular Ca 2+ mobilization and stimulation of protein kinase C (PKC), and eventually lead to the activation of several transcriptional factors. Emerging data suggest that G ␣ 16 participates in the activation of transcriptional factors such as signal transducer and activator of transcription 3 (STAT3) and nuclear factor B (NF-B). It has been demonstrated that C5a-induced phosphoinositide accumulation and Ca 2+ release are impaired in macrophages from G ␣ 15 -/-mice, despite of the normal hematopoiesis in these mice as well as in G ␣ 15 -/-G ␣ q -/-double-knockout and G ␣ 11 -/-mice, suggesting that there is functional redundancy in G q class signaling [9] . G ␣ 16 is coupled to a wide variety of receptors that are not linked to G ␣ q/11 . The receptor promiscuity of G ␣ 16 and its exclusive expression in the hematopoietic system indicate that it has unique functions in hematopoietic cells not performed by other G q subfamily members. This review summarizes the divergent biochemical features of G ␣ 16 , and provides newly appreciated and logical speculations of the biological functions of this G protein.
Covalent Modifications of G ␣ 16
Like other members of the G q subfamily, G ␣ 16 is predicted to be palmitoylated at its N-terminus. Three cysteine residues are located at the N-terminus of G ␣ 16 , and recent data suggest that Cys 9 and Cys 10 but not Cys 13 are palmitoylated ( fig. 1 ) [10] . Together with the polybasic residues found on the N-terminus of G ␣ 16 , such modifications are critical for plasma membrane attachment and PLC ␤ activation [10] . So far there is no other type of covalent modification detected on the N-terminus of G ␣ 16 , and it is not known if the palmitoylation of G ␣ 16 is dynamically regulated [11] or whether there is any heterogeneity of the attached lipid moiety as that in G ␣ z [12] .
G ␣ 16 is subjected to regulation by protein phosphorylation. The coupling of thyrotropin-releasing hormone receptor to G ␣ 16 in Xenopus oocytes is impaired by the activation of PKC [13] . Such regulation is unique among the members of the G q subfamily. In vitro phosphorylation study shows that G ␣ 16 is a direct substrate of PKC, and the phosphorylation site has eventually been identified as Ser 336 on the unique long insert of the ␣ 4/ ␤ 6 loop of G ␣ 16 ( fig. 1 ) [14] , which is a critical receptor-interacting region as identified in another study [15] . Similar PKC-mediated phosphorylation has been noted with the murine homolog G ␣ 15 and the phosphorylation site falls in the same region [14] . The constitutive activity of the GTPase-deficient (Q 212 L) mutant of G ␣ 16 in PLC ␤ activation is only weakly affected by the phosphorylation. Residual phosphorylation is observed in the G ␣ 16 Ser 336 mutant but not the quadruple mutant made in an earlier study [13] , indicating that PKC might also phosphorylate the other three putative target sites (Ser 4 , Thr 6 and Ser
53
). Since PKC is a major downstream effector of PLC ␤ , the action of PKC on G ␣ 16 may serve as a negative feedback mechanism to limit the activity of G ␣ 16 . To date, no oth- ␣N  ␣1  ␣A  ␣B -␣F  ␣2  ␣3  ␣G ␣4  ␣5  ␤1  ␤2␤3  ␤4  ␤5  ␤6  L1 ␣ -Helices and ␤ -strands are colored in orange and blue, respectively. The two green linker regions (L1 and L2) connect the two major tertiary structural domains -helical and GTPase domains -of G ␣ 16 . The amino acid sequences corresponding to the N-terminus and part of the ␣ 4/ ␤ 6 loop are shown, with the palmitoylated cysteines and the PKC phosphorylation site indicated in blue and green, respectively. Numbers in superscripts within the sequences correspond to the positions of the modified residues. Four known receptor-interacting regions on G ␣ 16 are marked below the schematic structural diagram, and are illustrated in a hypothetical G ␣ 16 structure. The model was generated by homologous modeling using Swiss-Model [87] and the template structures of G ␣ i1 and G ␣ t1 in their corresponding trimeric G protein structures [88, 89] . The view shows the putative receptor-interacting surface on the GTPase domain of G ␣ 16 , with the four receptor-interacting regions highlighted in yellow. The PKC phosphorylation site on ␣ 4/ ␤ 6 loop is highlighted by space-filled representation.
er report shows the interaction of G ␣ 16 with other serine/ threonine or tyrosine kinases.
A recent study shows that G ␣ 16 (and G ␣ q ) is degraded through proteasome pathway [16] . Proteasome inhibitors like MG132 and lactacystin block the G ␣ 16 degradation, whereas other non-proteasomal inhibitors show no obvious protection. The rate of degradation increases in the case of a palmitoylation-deficient mutant of G ␣ 16 , indicating that receptor-induced cytosolic translocation of G ␣ 16 may facilitate its proteasomal degradation. Although there is no evidence for direct ubiquitination of G ␣ 16 in that study, two potential non-consensus ubiquitination sites (Arg 37 and Arg
302
) can be found [17] . It would be interesting to examine if ubiquitination of G ␣ 16 occurs in vivo.
Promiscuous Receptor Coupling of G 16
One of the interesting features of G 16 is its promiscuous receptor-coupling property, which channels a wide variety of GPCRs to activate PLC ␤ and induce rapid intracellular Ca 2+ mobilization ( table 1 ) [18] . Such a discovery has facilitated the deorphanization of novel GPCRs and a number of successful cases have been reported [reviewed in [19] [20] [21] . However, G ␣ 16 is far from being the ideal 'universal adaptor' for all kinds of GPCRs. Significant and increasing numbers of GPCRs are found to be incapable of recognizing G 16 [discussed in 22, 23] and most of them belong to the G i -coupled receptors. The quest of a 'better coupler' has evolved based on the early finding that the extreme C-terminal tails of G ␣ subunits determine the receptor-coupling specificity [24, 25] . Substitutions of the C-terminal residues in the ␣ 5 helix of G ␣ 16 with those of either G ␣ i2 , G ␣ o1 or G ␣ z can greatly enhance the coupling with G i -linked receptors that normally do not interact with G ␣ 16 [23, 26] . The same strategy worked equally well for G s -coupled receptors [27] . Chimeric G ␣ 16 subunits with broadened receptor-coupling capability have been successfully employed in high throughput screening platforms [23, [28] [29] [30] . Further efforts have been made to decipher the minimal requirements for switching the receptor-coupling specificity. Individual residue lying on the exposed surface of the ␣ 5 helix of G ␣ 16 , as well as a stretch of six amino acids between the ␣ 5 helix and the extreme C-terminal tail, plays an important role in determining the receptor-coupling specificity [30] . Other potential receptor-interacting regions on G ␣ 16 have also been explored, such as the ␤ 2/ ␤ 3 loop [30] , ␣ N/ ␤ 1 loop [31] , as well as the uniquely long ␣ 4/ ␤ 6 loop ( fig. 1 ) [14] . Preliminary data from our laboratory indicate that reduction of the long ␣ 4/ ␤ 6 loop of G ␣ 16 [33] . Yet, co-expression of -OR with ␦ -OR or OR-like receptor 1, but not -OR, attenuates the U50,488-elicited G 16 -mediated PLC ␤ activation [34] . Conformational changes of the 6th and 7th membrane-spanning helices of -OR have been studied by substituting cysteine residues with serines and assessing their accessibilities by sulfhydryl reagent (2-aminoethyl)methanethiosulfonate. Interestingly, non-overlapping cysteine residues are found to be sensitive to the sulfhydryl reagent when -OR is co-expressed with either G ␣ 16 or G ␣ i2 [35] . Furthermore, the affinity of salvinorin A and U69593, but not dynorphin A (1-13), towards -OR is significantly enhanced when G ␣ 16 is coexpressed [35] . These results suggest that G 16 can functionally alter the ligand selectivity of the coupled receptor, thereby affecting the pharmacological outcome through the confinement of a subpopulation of the receptors at a particular active state. The concept of receptor-based biased functional selectivity caused by the presence of a defined set of G proteins [36, 37] has been reported [38, 39] . This phenomenon of biased ligand may profoundly affect the functions of GPCRs that are coupled to G 16 .
Transcriptional Activation by G ␣ 16
It is believed that G ␣ 16 has highly organized mechanisms for sorting and amplifying transmembrane signals due to its finely tuned expression regulation. With its unique expression in the hematopoietic lineages, it is plausible that G ␣ 16 may play a role in hematopoietic cell differentiation and function. Although the underlying mechanisms as to how G ␣ 16 is involved in the regulation of lineage exclusion and maturation remain elusive, there is evidence suggesting that G ␣ 16 mediates the activation of several important transcription factors such as STATs and NF-B. In combination of the importance of the In human erythroleukemia (HEL) cells where G ␣ 16 and G ␣ 14 are endogenously expressed, stimulation of the prostacyclin receptor by its specific agonist cicaprost induces STAT1 and STAT3 phosphorylation in a PTX-insensitive manner. In addition, phosphorylations of extracellular signal-regulated kinase (ERK) and JNK, but not p38 mitogen-activated protein kinase, can also be induced by cicaprost [43] . Another study indicated that in human embryonic kidney 293 (HEK293) cells expressing a STAT3-responsive luciferase reporter, the G ␣ 16 -coupled opioid receptor-like (ORL 1 ) and formyl peptide (fMLP) receptors stimulated luciferase activity upon stimulation by specific agonists. Co-expression of G ␣ 16 was required and the GPCR-mediated STAT3 activation was dependent on JAK and Raf-1 signaling [44] . More detailed illustration for the requirements of PLC ␤ /PKC/CaMKII, Ras/Raf-1/ERK and Rac1 in the activation of STAT3 is accomplished by the application of constitutively active G ␣ 16 (G ␣ 16 QL) in heterologous expression systems using HEK293 cells. The non-receptor tyrosine kinases, c-Src, JAK2 and JAK3 are also involved as demonstrated by the use of specific inhibitors and dominant-negative mutants ( fig. 2 ) [45] . G ␣ 16 QL induces STAT1-dependent c-fos transcriptional activation via PLC ␤ , c-Src/JAK and ERK pathways [46] . The differential involvements of STAT1 and STAT3 in G ␣ 16 -induced signaling pathways reveals that there are functional differences between these two STAT proteins, although they can always be activated by the same stimuli and form homo-and heterodimers [47, 48] . The biological effects of these two proteins can be antagonistic, as revealed by their actions on cell growth and survival. Given that G ␣ 16 can activate STAT1 and STAT3 simultaneously, the ultimate response of a particular cell type will depend on the availability of the two STAT proteins as well as the delicate control of the balanced levels between the homo-and/or heterodimer of STAT1 and STAT3.
In addition to the regulation of STAT activity, G ␣ 16 can couple to chemoattractant receptors such as CCR8, C3a, C5a, and fMLP receptors to activate NF-B, but the detailed signaling pathways involved have not been delineated [49, 50] . In the resting state, the two subunits of NF-B, p65 and p50, are retained in the cytosol by anchoring to the inhibitor-B ␣ (I B ␣ ). Upon cell activation, an upstream I B kinase (IKK) complex comprised of the catalytic subunits (IKK ␣ and IKK ␤ ) and a linker subunit (IKK ␥ ) becomes activated, and subsequently phosphorylates I B ␣ , leading to the degradation of I B ␣ . The released heterodimer then translocates into the nucleus and promotes NF-B-dependent transcription. Studies of other G 16 -coupled receptors provide hints on how G 16 may regulate NF-B. Adenosine A 1 receptor (A 1 R) can couple to both G ␣ i [51] and G ␣ 16 proteins [23, 33] . Stimulation of Reh cells with A 1 R agonist, N 6 -cyclohexyladenosine, results in PTX-insensitive phosphoryla- fig. 2 ) [52] .
The ability to integrate incoming signals is an important feature of biological systems. The final biological response is the combinational consequences of cell-type specificities, the strength and duration of the signals, and the balanced effects between the elicited signaling pathways. More than one transcription factor might be activated upon encountering a single extracellular stimulation. Recent studies from our laboratory have demonstrated that Lkn-1 stimulation of G ␣ 16 /G ␣ 14 -coupled CCR1 leads to the activation of both STAT3 and NF-B in HEK293 cells expressing CCR1 together with G ␣ 14 or G ␣ 16 [unpubl. data]. G ␣ 16 may be involved in the modulation of growth factor receptor signaling. Exogenous expression of G ␣ 16 QL in Swiss 3T3 cells results in the growth inhibition of the cells, and downregulation of the signal pathway in response to platelet-derived growth factor [53] . Transfection of constitutively active G ␣ 16 QL markedly enhance tumor necrosis factor-␣ -induced NF-B reporter activity in HeLa cells [50] . It has also been revealed that preactivation of G ␣ q family members including G ␣ 16 permits subsequent stimulation of PLC ␤ by G i -coupled receptors through the release of G ␤ ␥ dimer. In transiently transfected COS-7 cells, agonists binding of the G i -coupled ␦ -and -opioid receptors cannot stimulate PLC ␤ unless they are co-expressed with G ␣ 16 [54] . Another study shows that leukotriene B 4 receptor can activate PLC ␤ 2 -mediated IP accumulation via G ␣ i2 -derived G ␤ ␥ , and a synergistic effect could be observed when these cells co-express G ␣ 16 [55] . Given that both G ␣ i2 and G ␣ 16 are expressed in the hematopoietic cells [1, 56] , the physiological relevance of the synergistic actions mediated by these two G ␣ subunits deserves further investigations. Altogether, these studies suggest that activation of G 16 can synergize the effects of cytokines and other GPCRs in regulating transcriptional events.
Binding Partners of G ␣ 16
New insights on the functions of G 16 can be gleaned from the discovery of novel binding partners of G ␣ 16 . Recently, an adaptor protein called tetratricopeptide repeat 1 (TPR1) was found to bind to G ␣ 16 in yeast two-hybrid screening [57] . TPR1 is a 292-amino-acid protein containing three TPR motifs that was originally identified in the yeast cell division cycle protein Cdc23p [58] and the nuclear protein nuc2 [59] , and was subsequently found to be present in many other proteins [60] . It has been demonstrated that TPR1 interacts with Ha-Ras preferentially in its active form. Expression of G ␣ 16 , especially its constitutively active form strongly enhances the interaction between TPR1 and Ras ( fig. 1 ) [57] . In an attempt to define the structural requirement for G ␣ 16 to interact with TPR1, a series of G ␣ chimeras have been constructed in our laboratory to test for their association with TPR1. Our preliminary data indicated that a stretch of six amino acids (201) (202) (203) (204) (205) (206) Regulators of G protein signaling (RGS) protein binds to the active G ␣ subunits and stabilizes the transition state of G ␣ -catalyzed GTP hydrolysis, resulting in the acceleration of GTP hydrolysis, and therefore, termination of G protein signaling [61] . Among the more than 30 RGS proteins identified to date, only RGS2 has been shown to interact with G ␣ 16 and block of PLC ␤ signaling. RGS2 also inhibited IP production in HEK293 cells expressing the constitutively active G ␣ 16 QL [62] . Interestingly, GRK2 (a GPCR kinase bearing some resemblance to RGS proteins) selectively interacts with G ␣ q over G ␣ 16 [62] . GRK2 binds to the 'switch loops' of G ␣ q and inhibits its signaling [63] . The amino acid sequence of the switch loop region of G ␣ 16 is notably different from that in other G ␣ q subfamily members [3] , which might account for the discrimination between G ␣ q and G ␣ 16 in their binding to GRK2. It is possible that G ␣ 16 may interact with a unique array of RGS and RGS-like proteins.
Another recently identified G ␣ 16 -binding partner, p63RhoGEF, belongs to the guanine nucleotide exchange factor (GEF) family. p63RhoGEF contains the Dbl and pleckstrin homology domains [64] , and has been described as a novel mediator of G ␣ q/11 signaling to enhance RhoA activation [65, 66] . Physical association between G ␣ 16 and p63RhoGEF has been recently demonstrated in our laboratory. Further investigation revealed that instead of the enhancement of RhoA signal, overexpression of p63RhoGEF and G ␣ 16 in HEK293 cells inhibits PLC ␤ 2 activation and its downstream signaling such as the stimulation of transcription factors STAT3 and NF-B [unpubl. data]. These results suggest that p63RhoGEF may play differential roles in regulating the signaling of different G q subfamily members.
G ␣ 16 Expression during Myeloid Differentiation
G ␣ 16 expression fluctuates significantly during lineage differentiation [1, 67] . The pluripotent hematopoietic stem cells in the bone marrow can be divided into two types of progenitors -a common lymphoid progenitor that gives rise to natural killer cells and T and B lymphocytes, and a common myeloid progenitor that gives rise to different types of leukocytes, erythrocytes and megakaryocytes that produce platelets. The leukocytes include monocytes, the myeloid dendritic cells, and neutrophils, eosinophils and basophils. The latter three are generally termed granulocytes. G ␣ 16 protein expression is high in normal CD34
+ cells (CD34 is the surface marker for the hematopoietic progenitor cells), then decreases sharply when differentiating into granulocytes and erythrocytes [67] . In contrast, expression of G ␣ 16 protein remains high during normal monocytic differentiation and in HL60 cells (committed myeloid precursor cell line) differentiating into monocytes when induced by phorbol 12-myristate 13-acetate (PMA) or interferon-␥ [67] . Acute leukemias are clonal diseases in which the malignant cells lose their differentiation capacity. In primary myeloid leukemoblasts, as well as leukemic cell lines such as myeloid leukemia HL60, KG-1, HEL, and K562 cells, expression of G ␣ 16 protein is higher than that found in their normal CD34 + counterparts [1, 67] . These results imply that G ␣ 16 -dependent signaling may modulate cell proliferation or differentiation, depending on the specific cellular environment. Therefore, elucidating the functions of G ␣ 16 in hematopoietic cells, and identifying the surface receptors to which they couple, should lead to a better understanding of the mechanisms regulating human hematopoiesis and leukemogenesis.
Further information about the potential roles of G ␣ 16 accumulated from studies in which G ␣ 16 expression level or functional activity was altered. HEL cells endogenously express the P2Y 2 purinergic receptor that is coupled to G ␣ 16 . P2Y 2 -mediated elevation of intracellular Ca 2+ is suppressed in HEL cells expressing antisense G ␣ 16 ; the growth rate is also impaired in this cell line [68] . In MB-02 erythroleukemia cells containing a GFP-reporter system that associates with erythroid differentiation, overexpression of wild type, constitutively active G ␣ 16 , or transfection of a G ␣ 16 antisense plasmid led to significant growth inhibition and differentiation promotion [69] . This data indicate that an optimal functional level of G ␣ 16 is required for maintaining MB-02 cell proliferation, and any deviation from it will induce cell differentiation.
G ␣ 16 Expression during B-Cell Differentiation
In accordance with its expression in myeloid lineage, G ␣ 16 expression is restricted to progenitor B cells and poorly differentiated B-cell malignancies such as pre-Bacute lymphocytic leukemia, but not in its differentiated counterparts such as peripheral mature B cells and nonHodgkin's lymphoma [1, 70] . When a pre-B-cell line BLIN-1 is stimulated to undergo maturation development, G ␣ 16 expression was found to disappear during the transition from pre-B to B-cell differentiation stages [70] .
The G ␣ 16 -associated cell surface receptor of B-cell origin is largely unknown. However, there are several pieces of data indicating that GPCRs do exist on B cells and they might play important functional roles in modifying B-cell proliferation and differentiation. In blood cells, the most abundant known GPCRs are receptors for chemokines [71] . Other than the transduction of chemotactic signals, a number of chemokines are also believed to have functions in hematopoietic proliferation and differentiation. Although the definitive influence of chemoattractants on B cells remains elusive, recent studies have demonstrated that there is stage-specific microenvironment (niches) in the bone marrow for the development of B-cell progenitors [72] . A chemokine called stromal-derived factor-1 (SDF-1) plays a pivotal role in the migration and retention of B-cell progenitors in the bone marrow niches, which might indirectly affect their differentiation via cellular compartmentalization [73, 74] .
A number of viruses make use of GPCR mimetics to hijack our immune system. Kaposi's sarcoma-associated herpesvirus (KSHV) infects B cells and expresses a viral IL-8 receptor-like GPCR (KSHV-GPCR) which is constitutively active and also capable of binding various CXC chemokines including IL-8, SDF-1, IP-10 (interferon-␥ -inducible protein-10) [75, 76] . Exogenous expression of KSHV-GPCR in BJAB cells upregulates numerous cellular transcripts. The most abundantly in-duced genes are the CC chemokines macrophage inflammatory protein (MIP)-1 ␣ and -1 ␤ [77] . Activation of KSHV-GPCR induces the tyrosine phosphorylation of RAFTK (related adhesion focal tyrosine kinase, also known as Pyk2 and CAK ␤ ), a kinase that can be activated when cross-linking the B-cell receptor and acts as an oncogene to stimulate JNK and p38 [78] . Consequently, there appears to be a functional cross-talk between signals generated by ligation of B-cell receptor and KSHV-GPCR, leading to modulation of B-cell proliferation [78, 79] .
There is no evidence to indicate how G ␣ 16 might affect B-cell differentiation in the bone marrow. Strikingly, as revealed in an early report, PLC ␤ was not expressed in murine B cells throughout all developmental stages [80] . Therefore, signals elicited by G ␣ 16 -coupled receptors may not go through the conventional PLC ␤ -engaged pathways. Data from our laboratory suggests that activated G ␣ 16 may induce the activation of transcription factors in a PLC ␤ -independent manner. Interaction between G ␣ 16 and TPR1 allows the coupling of diverse receptors to the stimulation of Ras, as well as the subsequent activation of STAT3 [57] . A recent study shows that the absence of STAT3 impaired bone marrow B-cell development. Mice selectively lacking STAT3 in the bone marrow progenitor cells display reduced numbers of mature B cells which is believed to result from the diminished numbers of B-cell precursors including pro-, pre-, and immature B cells [81] . Given the fact that TPR1 is universally expressed and the fact that G ␣ 16 expression is dramatically disrupted during pre-B-to B-cell transition, it is conceivable that G ␣ 16 may regulate B-cell differentiation by modulating gene transcription at particular developmental stages through its interaction with TPR1.
G ␣ 16 Expression during T-Cell Activation
T cells originate from the hematopoietic stem cells in the bone marrow, and develop into mature naive T cells (CD4 + or CD8 + ) in the thymus. Many G ␣ subunits including G ␣ q/11 and G ␣ 16 have been identified in human thymocytes [82] . It has been suggested that a coordinated regulation of G ␣ 16 expression is required for optimal Tcell activation: G ␣ 16 protein expression reaches the highest level at day 4 in blood T cells after Leuco A stimulation and then decreases afterwards. Responses to Leuco A in Jurkat T cell are strongly inhibited when G ␣ 16 is overexpressed, and surprisingly, weak inhibition has also been observed when increases in G ␣ 16 expression were prevented expressing an antisense G ␣ 16 construct [83] . Collectively, these data suggest that alterations of G ␣ 16 expression impair activation-induced T-cell responses.
The T-cell receptor (TCR) complex consists of the highly variable ␣ : ␤ heterodimer which recognizes and binds antigen, the invariant CD3 complex (composed of CD3 ␥ , CD3 ␦ , and CD3 ) and chains. Upon anti-CD3-mAb engagement, G ␣ q/11 and G ␣ 16 are activated [84] , and TCR/CD3-mediated signaling is inhibited in Jurkat T cells expressing a dominant negative mutant of G ␣ 16 [85] . A profound defect in the production of IL-2 and IL-10, as well as in the expression of CD69 was observed. Accordingly, significant reductions in anti--induced tyrosine phosphorylation of , , ZAP-70 ( -associated protein 70) and intracellular Ca 2+ mobilization are detected. Similarly, TCR/CD3-mediated activation of two Src-family tyrosine kinases, Fyn and Lck, are also reduced by the same G ␣ 16 mutant. However, the PMA-induced IL-10 production and CD69 expression, and the ionomycin plus PMA-induced IL-2 production are not affected in mutant G ␣ 16 -expressed Jurkat cells. Together, these results imply a crucial functional role of G 16 in TCR signaling. Recently, we have performed co-immunoprecipitation studies and confirmed that G ␣ 16 is physically associated with the TCR, and the observed interaction is dependent on the activation of G ␣ 16 but not the T cells. Constitutively active G ␣ i subunits are unable to co-immunoprecipitate with the TCR, suggesting the specificity of the interaction between G ␣ 16 and TCR [unpubl. data]. These studies provide further supportive evidence for the specific association between G ␣ 16 and the TCR complex, and raise the possibility that signaling through G ␣ 16 -coupled receptors may affect the activation of T cells. Similar results have been obtained regarding the co-stimulation of T cells by chemokine receptors coupled to G ␣ q and/or G ␣ 11 via their recruitment to the immunological synapse [86] . Altogether, these results increase our understanding of the molecular mechanisms responsible for the involvement of G ␣ 16 in T-cell activation.
Conclusion
We have outlined the evidence demonstrating the distinctive biochemical properties of G ␣ 16 , together with its proven and speculated biological functions. Identification of the covalent modifications of G ␣ 16 , which are important for its membrane targeting and signal transduction, is extremely helpful in our appreciation of its func-tional activity. Sequence substitutions and mutations of G ␣ 16 help to illustrate the receptor binding promiscuity and advance our understanding of its receptor-coupling capability and specificity. Great achievements have been made in the delineation of the G ␣ 16 -associated signaling molecules and pathways involved in the activation of the transcription factors, which allow the appreciation to the complexity of the linked signaling network. G ␣ 16 is uniquely expressed in the hematopoietic cells and in tissues harboring these cells. Some progress about its functions in hematopoietic development and differentiation has been achieved since its discovery. However, due to technical limitations such as the low efficiency of hematopoietic cell transfection, and the complexity of lineage maturation network, questions as to how exactly G ␣ 16 fits into the hematopoietic signaling and development remain unaddressed. The signaling complexity, and the receptor binding promiscuity, together with its restrained cell/tissue distribution, raises the possibility that G ␣ 16 is able to elicit a unique profile of signaling events and cellular responses. It is of great interest in the future to investigate the biological function of G ␣ 16 and its involvement in the cross-talk with other signaling pathways such as BCR-and TCR-induced lymphocyte differentiation and activation.
